- Home
- BFS vs VSTM Comparison
BFS vs VSTM Comparison
Compare BFS & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BFS | VSTM |
|---|---|---|
| Founded | 1993 | 2010 |
| Country | United States | United States |
| Employees | N/A | 102 |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 902.2M | 1.1B |
| IPO Year | 1996 | 2011 |
Fundamental Metrics
Financial Performance| Metric | BFS | VSTM |
|---|---|---|
| Price | $28.38 | $8.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 10 |
| Target Price | ★ $42.00 | $17.22 |
| AVG Volume (30 Days) | 115.8K | ★ 3.8M |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | ★ 8.30% | N/A |
| EPS Growth | N/A | ★ 17.49 |
| EPS | ★ 0.78 | N/A |
| Revenue | ★ $289,843,000.00 | $30,914,000.00 |
| Revenue This Year | $7.69 | $262.65 |
| Revenue Next Year | $3.08 | $38.45 |
| P/E Ratio | $36.41 | ★ N/A |
| Revenue Growth | 7.81 | ★ 209.14 |
| 52 Week Low | $28.13 | $3.43 |
| 52 Week High | $38.42 | $10.82 |
Technical Indicators
Market Signals| Indicator | BFS | VSTM |
|---|---|---|
| Relative Strength Index (RSI) | 38.50 | 42.54 |
| Support Level | N/A | $7.10 |
| Resistance Level | $35.04 | $8.59 |
| Average True Range (ATR) | 0.64 | 0.55 |
| MACD | 0.01 | -0.21 |
| Stochastic Oscillator | 21.09 | 22.53 |
Price Performance
Historical ComparisonAbout BFS Saul Centers Inc.
Saul Centers Inc is a self-managed real estate investment trust which invests in, operates and develops retail and commercial properties. The company's portfolio includes community and neighbourhood shopping centres, office properties, and mixed-use properties. Properties are located in the Washington, D.C. and Batlimore metropolitan areas. Saul Centers operates through two business segments: Shopping Centers segment, which contribute the maximum portion of total revenue; and mixed-use properties.Mixed-Use Properties segment include office, retail and multi-family residential use.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.